Morgan Dudley

November 6, 2022

‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer

Abstract Introduction: Following 2016 legislation permitting limited access to cannabis for research and medicinal purposes, the number of randomized clinical…

September 5, 2022

Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer

Abstract Background: Recruitment for randomised controlled trials in palliative care can be challenging; disease progression and terminal illness underpin high…